BDBM62577 3-(Thiazol-2-ylaminomethylene)-1,5-dioxa-spiro[5.5]undecane-2,4-dione::3-[(1,3-thiazol-2-ylamino)methylidene]-1,5-dioxaspiro[5.5]undecane-2,4-dione::3-[(2-thiazolylamino)methylidene]-1,5-dioxaspiro[5.5]undecane-2,4-dione::3-[(thiazol-2-ylamino)methylene]-1,5-dioxaspiro[5.5]undecane-2,4-quinone::MLS000030756::SMR000012140::cid_655814

SMILES COCCN1Cc2cc(N3CCCc4cc(C(=O)N5CCC(F)(F)CC5)cnc43)ccc2C1=O

InChI Key InChIKey=QTEXIASATCIBHB-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62577   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62577BDBM62577(US12577217, Example 1-82)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent